Research has shown that ITGB2 is highly expressed in a number of cancers, such as colorectal cancer, renal clear-cell carcinoma, papillary thyroid cancer, and breast cancer [50]. This evidence concerns the gene ITGB2 and clear cell renal carcinoma.